Shenyang Chest Hospital

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Tuberculosis2 trials

Phase

• Phase 32 trials

Status

• Active, not recruiting2 trials

Lead sponsor

• Beijing Chest Hospital1 trial
• Huashan Hospital1 trial

Running trials

• Active, not recruiting

  Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort

  NCT06649721· Phase 3· Huashan Hospital· Source

• Active, not recruiting

  Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort

  NCT06081361· Phase 3· Beijing Chest Hospital· Source